We estimated the effects of EAAs on various health outcomes, including T2D, hypertension, alanine aminotransferase (ALT), aspartate aminotransferase (AST), high density lipoprotein (HDL), triglyceride (TG), and high sensitivity C-reactive protein (hs-CRP), percentage of predicted FEV1 (FEV1% PRED), and percentage of predicted FVC (FVC% PRED). This evidence concerns the gene GPT and hypertensive disorder.